Jing Lou

Dr. Jing Lou is a co-founder of 3SBio Group and currently serves as the chairman of the board of directors, the chief executive officer and president of 3SBio Group. He is responsible for the strategic development and planning, overall operational management and major decision making of 3SBio Group.

Dr. Lou has extensive experience in capital markets transactions and initial public offerings. Dr. Lou lead 3SBio Inc.’s IPO on Nasdaq, one of the few high profile IPOs in the U.S by Chinese pharmaceutical companies. Taking the opportunity of Hong Kong capital market, Dr. Lou successfully led the privatization and delisting of 3SBio Inc. from Nasdaq and relisting it on the Hong Kong Stock Exchange. Dr. Lou also lead the landmark acquisition of Sunshine Guojian, and subsequent listing of Sunshine Guojian on Shanghai Stock Exchange STAR Market.